Literature DB >> 2162498

Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.

B E Smith1, P J Dyck.   

Abstract

Eosinophilia, brawny induration, and tenderness of the skin and deeper tissues, and eosinophilic and lymphocytic infiltration of skin, deep fascia, and muscle characterize the acute eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. Many patients have a florid inflammatory myopathy. We evaluated 10 patients with this syndrome in whom peripheral neuropathy was a prominent or the only presenting feature. Two of these patients with severe neuromuscular disease required mechanical ventilation, and 1 died. Clinical severity appeared to be positively associated with the total dose of L-tryptophan ingested. Although the inflammation is generally thought to be more severe in skin, fascia, and muscle, inflammation, especially in the epineurium of sural nerve, was sometimes striking and often accompanied by vasculopathy and angioneogenesis. These cases draw attention to a new preventable syndrome with peripheral nerve involvement, emphasize the value of tissue biopsy for its diagnosis, and raise issues related to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162498     DOI: 10.1212/wnl.40.7.1035

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  The idiopathic inflammatory myopathies and their treatment.

Authors:  J Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

Review 2.  Tryptophan. Current status and future trends for oral administration.

Authors:  L D Kaufman; R M Philen
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

3.  A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).

Authors:  R M Silver; A Ludwicka; M Hampton; T Ohba; S A Bingel; T Smith; R A Harley; J Maize; M P Heyes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 4.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

5.  Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.

Authors:  M L Freimer; J D Glass; V Chaudhry; W R Tyor; D R Cornblath; J W Griffin; R W Kuncl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

6.  Peripheral nerve involvement in Churg-Strauss syndrome.

Authors:  R Marazzi; D Pareyson; A Boiardi; M Corbo; V Scaioli; A Sghirlanzoni
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

7.  Multifocal peripheral neuropathy in eosinophilic fasciitis.

Authors:  J Satsangi; M Donaghy
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.